此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

选择性剖腹产中使用与不使用膀胱导尿术

2026年9月14日 更新者:University of Calgary

择期剖宫产中使用与不使用膀胱导尿术的随机对照试验

The goal of this randomized controlled trial is to investigate the impact of routine bladder catheterization in uncomplicated cesarean sections on time to ambulation, time to discharge, urinary retention, development of urinary tract infections, prevention of bladder injury, operating time, and patient satisfaction.

研究概览

地位

完全的

详细说明

This would be a randomized controlled trial conducted on the labour and delivery and post-partum unit at a large academic site (Foothills Medical Centre) in Calgary, Alberta. Study recruitment of patients awaiting delivery via CS would occur either in participating prenatal clinics in Calgary or in obstetrical triage by a trained nurse research assistant. Participants would be randomized into either a catheterized or non-catheterized group prior to their scheduled elective CS. Allocation concealment will be ensured by using either a central computer generator for randomization if funding permits, otherwise sealed, opaque, and sequenced envelopes will be used. Since there may be potential differences in patients with increasing parity, randomization will be stratified by parity and blocked to prevent imbalance in treatment groups.

研究类型

介入性

注册 (实际的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Alberta
      • Calgary、Alberta、加拿大、T2N 2T9
        • University of Calgary

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

女性

描述

Inclusion criteria:

- women who are 18 years of age or older with a singleton pregnancy presenting for an elective primary or repeat CS.

Exclusion criteria:

- diagnosis of abnormal placentation including placenta previa, vasa previa, or suspected invasive disease

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Bladder catheterization

Patients placed in the catheterized group will have an indwelling catheter placed after anesthetic has been administered. It would be removed at 12 hours post Cesarean section.

Patients placed in the catheterized group will have an indwelling catheter placed after anesthetic has been administered. It would be removed at 12 hours post cesarean section.

无干预:Non-use of bladder catheterization

Participants in the non-catheterized group would be encouraged to empty their bladders just prior to transfer to the operating room where they will undergo surgery without an indwelling catheter.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Time to ambulation
大体时间:Prior to discharge, assessed up to 3 days postpartum

Time to ambulation will be collected via a form that will be distributed by the postpartum nursing team.

Prior to discharge, assessed up to 3 days postpartum

次要结果测量

结果测量
措施说明
大体时间
Incidence of urinary retention
大体时间:Prior to discharge, assessed up to 3 days postpartum

Urinary retention will be defined based on a patient's inability to spontaneously void requiring either in-and-out catheterization or placement of an indwelling catheter during the post operative course

Prior to discharge, assessed up to 3 days postpartum
Incidence of urinary tract infections (UTI) requiring antibiotics in the first 4 weeks postpartum
大体时间:first 4 weeks postpartum

Incidence of urinary tract infections (UTI) requiring antibiotics in the first 4 weeks postpartum

first 4 weeks postpartum
Incidence of bladder injury in surgery
大体时间:During surgery

Incidence of bladder injury in surgery will be collected via an electronic post-operative questionnaire filled out by the operating surgeon.

During surgery
Operating time
大体时间:During surgery

Operating time will be collected via an electronic post-operative questionnaire filled out by the operating surgeon.

During surgery
Patient satisfaction as measured by the Maternal Satisfaction for Cesarean Section questionnaire (MSCS)
大体时间:At discharge, assessed up to 3 days postpartum

Patients will be asked to complete the Maternal Satisfaction for Cesarean Section questionnaire at discharge. The minimum and maximum values are 7 and 154 and higher scores mean a better outcome.

At discharge, assessed up to 3 days postpartum
Time to discharge
大体时间:At discharge, assessed up to 3 days postpartum

Time to discharge; date and time of discharge will be collected during chart review

At discharge, assessed up to 3 days postpartum

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Stephen L. Wood, MD, MSc、University of Calgary

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年8月27日

初级完成 (实际的)

2026年2月18日

研究完成 (实际的)

2026年2月18日

研究注册日期

首次提交

2024年1月19日

首先提交符合 QC 标准的

2024年2月2日

首次发布 (实际的)

2024年2月5日

研究记录更新

最后更新发布 (实际的)

2026年9月18日

上次提交的符合 QC 标准的更新

2026年9月14日

最后验证

2025年2月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅